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Ca2+ release from intracellular stores is controlled by complex interactions between multiple proteins. Triadin is a 
transmembrane glycoprotein of the junctional sarcoplasmic reticulum of striated muscle that interacts with both 
calsequestrin and the type 1 ryanodine receptor (RyR1) to communicate changes in luminal Ca2+ to the release 
machinery. However, the potential impact of the triadin association with RyR1 in skeletal muscle excitation–con-
traction coupling remains elusive. Here we show that triadin binding to RyR1 is critically important for rapid Ca2+ 
release during excitation–contraction coupling. To assess the functional impact of the triadin-RyR1 interaction, we 
expressed RyR1 mutants in which one or more of three negatively charged residues (D4878, D4907, and E4908) in 
the terminal RyR1 intraluminal loop were mutated to alanines in RyR1-null (dyspedic) myotubes. Coimmuno-
precipitation revealed that triadin, but not junctin, binding to RyR1 was abolished in the triple (D4878A/D4907A/
E4908A) mutant and one of the double (D4907A/E4908A) mutants, partially reduced in the D4878A/D4907A 
double mutant, but not affected by either individual (D4878A, D4907A, E4908A) mutations or the D4878A/E4908A 
double mutation. Functional studies revealed that the rate of voltage- and ligand-gated SR Ca2+ release were reduced 
in proportion to the degree of interruption in triadin binding. Ryanodine binding, single channel recording, and 
calcium release experiments conducted on WT and triple mutant channels in the absence of triadin demonstrated 
that the luminal loop mutations do not directly alter RyR1 function. These fi  ndings demonstrate that junctin and 
triadin bind to different sites on RyR1 and that triadin plays an important role in ensuring rapid Ca2+ release during 
excitation–contraction coupling in skeletal muscle.
INTRODUCTION
Ca2+ signaling in most cells depends on Ca2+ release 
from intracellular stores. The effi  ciency of Ca2+ release 
is determined by the Ca2+ binding capacity of the store 
proteins and the activity of Ca2+ release channels in the 
store membrane. The Ca2+ store in striated muscle, the 
SR, plays a central role in the vital functions of move-
ment, respiration, and heart beat (Rossi and Dirksen, 
2006). The key Ca2+ binding protein in the SR is calse-
questrin (CSQ) and the Ca2+ release channel is the ry-
anodine receptor (RyR) (Zhang et al., 1997; Beard 
et al., 2004). CSQ not only binds Ca2+ but also regulates 
Ca2+ release by communicating with the RyR via two 
intermediary proteins, triadin and junctin (Beard et al., 
2002; Gyorke et al., 2004; Wei et al., 2006), which are 
found in many tissues and play a ubiquitous role in Ca2+ 
signaling. Both are transmembrane proteins that bind 
to CSQ and the RyR (Jones et al., 1995) to form a CSQ/
triadin/junctin/RyR “luminal Ca2+ transduction machine” 
that is central to Ca2+ release unit function (Beard et al., 
2002, 2004; Gyorke et al., 2004; Wei et al., 2006) and 
assembly (Tijskens et al., 2003).
Triadin is a junctional SR protein discovered in 1990 
by Brandt et al. (1990) that was originally proposed to 
play a critical role in excitation–contraction (EC) cou-
pling (Kim et al., 1990). However, since the bulk of the 
protein is located within the SR lumen where it binds to 
CSQ and the RyR (Knudson et al., 1993b; Guo and 
Campbell, 1995), it is currently believed to facilitate 
cross-talk between CSQ and the RyR (Beard et al., 2002), 
rather than directly infl  uence EC coupling (Gyorke et al., 
2004). Junctin was later discovered and thought to have 
a comparable function to triadin, due to its similar 
structure and ability to also bind CSQ and the RyR 
(Jones et al., 1995; Zhang et al., 1997; Tijskens et al., 
2003). The specifi  c residues in RyR1 that bind triadin 
and junctin are functionally relevant and, therefore, of 
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great interest. A putative triadin binding site was re-
cently identifi  ed in the terminal intraluminal loop of 
RyR1 between residues 4860 and 4917 (Lee et al., 2004). 
More recently, alanine substitution of three specifi  c neg-
atively charged residues within this region (D4878, D4907, 
and E4908) was found to disrupt triadin binding to full-
length RyR1 and also alter the magnitude and kinetics 
of caffeine-induced Ca2+ release (Lee et al., 2006). How-
ever, the relative impact of disrupting the triadin–RyR1 
interaction on Ca2+ release during EC coupling, potential 
direct effects of the mutations on RyR1 function that are 
unrelated to triadin binding, or effects of the mutations 
on junctin binding to RyR1 have not been investigated.
Here we demonstrate that the intraluminal RyR1 resi-
dues D4878, D4907, and E4908 contribute unequally 
(D4907 > E4908 > D4878) to triadin binding to RyR1 
and that this interaction is an important regulator of both 
voltage- and ligand-induced SR Ca2+ release in skeletal 
muscle. Moreover, we found that disruption of triadin 
binding to RyR1 did not affect junctional targeting of 
RyR1, RyR1 enhancement of dihydropyridine receptor 
(DHPR) calcium channel activity (retrograde coupling; 
see Dirksen, 2002 for review), or the ability of junctin to 
bind to RyR1. We propose a model whereby triadin bind-
ing to RyR1 enhances release channel opening in re-
sponse to both voltage- and ligand-induced activation 
and that this activity is important for ensuring robust and 
rapid calcium release during EC coupling.
MATERIALS AND METHODS
Preparation of Mutants and Nuclear Microinjection 
of Dyspedic Myotubes
The D4878A (∆M1), D4907A (∆M2), E4908A (∆M3), D4878A/
D4907A (∆M1,2), D4878A/E4908A (∆M1,3), D4907A/E4908A 
(∆M2,3), and D4878A/D4907A/E4908A (∆M1,2,3) mutations were 
introduced into a full-length rabbit RyR1 cDNA using standard 
two-step site-directed mutagenesis. All sequences generated and 
modifi  ed by PCR were checked for integrity by sequence analysis. 
Primary cultures of dyspedic myotubes were cultured from skele-
tal myoblasts isolated from newborn dyspedic mice (Nakai et al., 
1996; Avila et al., 2001). After allowing myoblasts to differentiate 
into multinucleated myotubes for 4–7 d, nuclei of individual myo-
tubes were microinjected with cDNAs encoding CD8 (0.1 μg/μl) 
and one of the RyR1 constructs at a concentration of 0.5 μg/μl. 
Expressing myotubes were subsequently identifi  ed 48–72 h after 
injection by incubation with CD8 antibody-coated beads (Dyna-
beads, Dynal ASA). All animals were anaesthetized and humanely 
killed following procedures that were reviewed and approved by 
the University Committee on Animals Resources at the University 
of Rochester School of Medicine and Dentistry.
Measurements of Electrically Evoked and Agonist-induced 
Ca2+ Transients in Myotubes
Intracellular Ca2+ measurements in intact myotubes were ob-
tained from Indo-1 AM (TefLabs Inc.) loaded myotubes (Avila 
et al., 2001). Cytosolic dye within a rectangular region of the cell was 
excited at 350 nm and fl  uorescence emission at 405 and 485 nm 
was measured at 100 Hz sampling frequency using a 40× oil 
objective, a photomultiplier detection system (Photon Technology 
International), and results are presented as the ratio of 405 and 
485 nm (F405/F485). These Ca2+ measurements were conducted in 
a normal rodent Ringer’s solution consisting of (in mM) 145 
NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, pH 7.4. Electrically 
evoked Ca2+ transients were elicited using fi  eld stimulation (8 V, 
20 ms) applied every 10 s. A caffeine (30 mM) or 4-chloro-m-
cresol (4-cmc, 500 μM) bolus was delivered at the end of the pro-
tocol to assess release channel expression and SR Ca2+ content. 
Data are presented as mean ± SEM with signifi  cance accepted at 
P < 0.01 (unpaired Student’s t test).
Simultaneous Measurements of Macroscopic Ca2+ Currents 
and Transients in Myotubes
Whole-cell patch clamp experiments were used to simultaneously 
measure voltage-gated L-type Ca2+ currents and Ca2+ transients 
(Avila et al., 2001). Peak L-current magnitude was normalized to 
cell capacitance (pA/pF) and plotted as a function of membrane 
potential (Vm) and fi  tted according to
  =− + − max m rev G1/2 m G I G (V V )/(1 exp[(V V )/k ]),  (1)
where Gmax is the maximal L-channel conductance, Vm is test po-
tential, Vrev is extrapolated reversal potential, VG1/2 is the voltage 
for half-maximal activation of Gmax, and kG is a slope factor. Rela-
tive changes in intracellular Ca2+ in these experiments were mea-
sured after dialysis with K5-Fluo-4 salt. Relative changes in Fluo-4 
fl  uorescence (∆F/F) were measured either 30 or 200 ms after de-
polarization, plotted as a function of Vm, and fi  tted according to
  Δ= Δ + − max F1/2 m F F/F ( F/F )/{1 exp[(V V )/k ]},  (2)
where (∆F/F)max is the calculated maximal change in fl  uores-
cence, VF1/2 is the voltage for half-maximal activation of (∆F/F)max, 
and kF is a slope factor. The bell-shaped voltage dependence of 
∆F/F measurements obtained in ∆M1,2,3- and ∆M2,3-expressing 
myotubes was fi  tted according to the following equation:
 (3)  
Δ= Δ − + − max m rev F1/2 m F F/F (( F/F) ((V V )/k'))/(1 exp((V V )/k )),
where (∆F/F)max, Vm, Vrev, VF1/2, and kF have their usual meanings. 
The additional variable k’ is a scaling factor that varies with 
(∆F/F)max (Sheridan et al., 2003; Goonasekera et al., 2005). Pooled 
current–voltage (I-V) and fl  uorescence–voltage (∆F/F-V) data 
in Table I are expressed as mean ± SEM. All patch clamp 
experiments were conducted in an external solution consisting 
of (in mM) 145 TEA-Cl, 10 CaCl2, and 10 HEPES (pH 7.4). The 
internal patch pipette solution consisted of (in mM) 145 Cs-
Aspartate, 10 CsCl, 0.1 Cs2-EGTA, 1.2 MgCl2, 5 Mg-ATP, 0.2 K5-
Fluo-4, and 10 HEPES (pH 7.4).
Measurements of 4-cmc-induced Ca2+ Transients 
in HEK293 Cells
HEK293 cells plated on coverslips were transfected with either 
WT RyR1 or ∆M1,2,3 cDNA (Jiang et al., 2002). 2 d after transfec-
tion, cells were loaded with 5 μM Fura-2 AM for 30 min at 37°C 
in Ringer’s solution. Coverslips of Fura-2–loaded cells were then 
mounted in a tissue chamber on the stage of an epifl  uorescence-
equipped inverted microscope. Cells were sequentially excited 
at 340- and 380-nm wavelength and fl  uorescence emission at 
510 nM was collected using a high-speed IMAGO-QE CCD 
camera (TILL Photonics). The results are presented as the ratio of 
F340/F380 (collected at 6.25Hz). Maximal increase in intracellular 
Ca2+ induced by addition of 4-cmc (500 μM) was defi  ned as the 
difference between peak and baseline fl  uorescence ratios dur-
ing agonist exposure.  Goonasekera et al. 367
Puriﬁ  cation of Triadin and Junctin
Triadin and junctin were purifi  ed from rabbit skeletal muscle as 
previously described (Mulvey and Ohlendieck, 2003) except 
that after separation by electrophoresis, proteins were eluted by 
gentle agitation at 37°C in a buffer containing 0.5% CHAPS, 
20 mM MOPS, and 150 mM NaCl (pH 7.4). Proteins were then 
dialyzed twice against 20 mM MOPS, 150 mM NaCl, pH 7.4. Pu-
rifi  cation was enhanced by immunoselection with anti-junctin 
or anti-triadin.
[3H]Ryanodine Binding and Single Channel Recording 
of Puriﬁ  ed RyRs
WT and ∆M1,2,3 RyR1 constructs were expressed and purifi  ed 
from HEK293 cells as previously described (Kimura et al., 2005; 
Kimura et al., 2007). [3H]Ryanodine binding was performed as 
previously described (Kimura et al., 2005), except that 5 mg of 
purifi  ed RyR1 protein was used in all experiments and in some 
experiments preincubation with triadin (5 μg/ml) was done for 
30 min on ice, before initiating [3H]Ryanodine binding. Single 
channel experiments were conducted as described in (Kimura 
et al., 2005), using the following conditions. To incorporate purifi  ed 
RyRs (WT or ∆M1,2,3), the standard incorporation solution con-
sisted of the following: cis: 230 mM Cs-methanesulfonate, 20 mM 
CsCl, 5 mM CaCl2, and 10 mM TES (pH 7.4); and trans: 30 mM 
Cs-methanesulfonate, 20 mM CsCl, 1 mM CaCl2, and 10 mM TES 
(pH 7.4). Immediately after channel incorporation, 200 mM 
Cs-methanesulfonate was added to the trans chamber (to ensure 
recording solution symmetry) and cis Ca2+ was adjusted to 1 mM, 
10 μM, or 100 nM by the addition of Ca2+ chelator (BAPTA). Chan-
nel activity was analyzed over 10–30-s periods of continuous activity 
at +40 and −40 mV. Slow fluctuations in the baseline were cor-
rected using an in-house program written by Dr. D.R. Laver. Chan-
nel activity was measured either as “mean current” (average of all 
data points) or as open probability (Po), using threshold analysis 
with the program Channel 2, (developed by Drs. P.W. Gage and 
M. Smith, JCSMR). Measurements of mean current, performed 
on 30-s records from bilayers containing one to four channels, in-
cluded all channel activity from small subconductance openings 
to maximum levels. Mean current divided by the maximum cur-
rent provides an approximate measure of Po. Po, mean open times 
(To), and mean closed times (Tc) were measured directly during 
periods of recording in which the opening of only a single chan-
nel was detected. Threshold levels for channel opening and clos-
ing were set at  20% of the maximum single channel conductance 
in order to exclude baseline noise.
Immunoprecipitations
Precleared purifi  ed skeletal muscle triadin or junctin were incu-
bated with either anti-triadin or anti-junctin antibody coupled to 
protein A/G sepharose and incubated with purifi  ed recombinant 
RyR1s (expressed in HEK293 cells) for 2 h at 4°C in a buffer con-
taining 20 mM MOPS, 150 mM NaCl, pH 7.4. Immunoprecipi-
tates were washed three times in 20 mM MOPS, 150 mM NaCl 
(pH 7.4), proteins eluted from the beads by boiling for 2–3 min 
in Laemmli sample buffer, and subjected to SDS-PAGE and 
immunoblot. Identical results were obtained using similar buffers 
containing 1 mM Ca2+. Reverse immunoprecipitation was per-
formed, using a sepharose/anti-RyR/RyR complex to assess binding 
of purifi  ed triadin and junctin to immobilized RyRs. Anti-RyR was 
obtained from Sigma-Aldrich. Each immunoprecipitation was re-
peated at least three times (n ≥ 3). Where appropriate, percent 
binding was calculated from three separate immunoprecipitates via 
immunoblot image analysis using the Genetools analysis software.
Immunoﬂ  uorescence Labeling
Expressing dyspedic myotubes plated on glass coverslips were 
fi  xed and immunostained with a mouse monoclonal anti-RyR 
antibody (34C, 1:10; Developmental Studies Hybridoma Bank) 
and a sheep polyclonal anti-DHPR antibody (1:200; Upstate Bio-
technology) overnight at 4°C as previously described (Graves 
and Hinkle, 2003). On the following day, coverslips were washed 
with PBS three times each for 5 min and then incubated for 1 h 
at room temperature in blocking buffer containing a 1:500 
dilution of Alexa Fluor 488–labeled donkey anti-mouse IgG 
(Molecular Probes) and 1:500 dilution of rhodamine-labeled 
donkey anti-sheep IgG (Jackson ImmunoResearch Laboratories 
Inc.) and washed with PBS (three times for 5 min each). Cover-
slips were mounted on glass slides and images obtained using 
a Nikon Eclipse-C1 confocal microscope (Nikon Instruments 
Inc.) and a 40× oil objective. All confocal images were sampled 
at a spatial resolution (pixel diameter) of 100 nm. A similar 
protocol was used to immunostain and obtain images from 
WT RyR1- and ∆M1,2,3-expressing HEK293 cells using antibody 
34C (1:20) and a rhodamine-conjugated goat anti-mouse 
IgG (1:2,000).
Figure 1.  Triadin and junctin binding to RyR1 luminal loop 
mutants. (A) Proposed interaction between triadin and the ter-
minal RyR1 luminal loop. (Top) Amino acid sequence for a por-
tion of the luminal loop between the fi  nal two transmembrane 
domains of the rabbit RyR1 protein. Negatively charged amino 
acids mutated in this study (D4878, D4807, and E4809 on the 
left and M1, M2, and M3 on the right in the schematic) are shown 
in italics. (Bottom) Representation of the triadin interaction 
with the terminal luminal loop of RyR1 is modifi  ed from Fig. 5 
of Lee et al. (2004). (B and C) Western blot analysis of proteins 
immunoprecipitated with anti-triadin (B) or anti-junctin (C). After 
incubation of the WT or mutant RyR1 (listed at the bottom of 
the blot) with either triadin (B) or junctin (C). Immunoprecipi-
tations were performed and the immunoprecipitated protein 
analyzed by Western Blot using anti-RyR and anti-triadin (B) or 
anti-junctin (C). 368 Triadin Regulation of Skeletal Muscle EC Coupling
RESULTS
Three Negatively Charged Residues in the C-terminal 
Intraluminal Loop of RyR1 Unequally Coordinate 
Triadin Binding
To determine the relative importance of the three nega-
tively charged RyR1 residues identifi  ed by Lee et al. 
(2004) (Fig. 1 A) for triadin and junctin binding to full-
length RyR1, we assessed the effects of a comprehensive 
series of mutations to these residues in triadin and junc-
tin coimmunoprecipitation. Purifi  ed skeletal triadin or 
junctin were coupled to protein A/G sepharose via anti-
triadin or anti-junctin antibodies (respectively), and as-
sociation with WT and mutated RyR1 constructs was 
determined by incubation with purifi  ed recombinant 
RyR1 constructs. In contrast to Lee et al. (2004), triadin 
binding to RyR1 was not altered by any of the single mu-
tants (D4878A, ∆M1; D4907A, ∆M2; E4908A, ∆M3) or for 
D4878A/E4908A (∆M1,3) (Fig. 1 B), with similar amounts 
of each mutant binding to triadin as that observed for 
WT RyR1. However, a 50% ± 12% (n = 3) reduction in 
triadin binding was observed for D4878A/D4907A (∆M1,2) 
while triadin binding to D4907A/E4908A (∆M2,3) and 
D4878A/D4907A/E4908A (∆M1,2,3) was undetectable 
(Fig. 1 B). Identical results were obtained in the absence 
of calcium (as in Lee et al., 2004) and in the presence of 
1 mM Ca2+. In addition, identical results were also ob-
served in reverse coimmunoprecipitation experiments 
in which purifi  ed WT RyR1 or ∆M1,2,3 were coupled to 
protein A/G sepharose via anti-RyR and their ability to 
pull down purifi  ed triadin and junctin was detected (un-
published data). In marked contrast to triadin, none of 
the luminal loop mutations signifi  cantly altered the abil-
ity of RyR1 to interact with junctin (Fig. 1 C) since the 
amount of each RyR1 mutant construct associated with 
junctin was similar to that of WT RyR1.
Our results in Fig. 1 were not infl  uenced by the use of 
purifi  ed proteins. In initial experiments, solubilized SR 
was used as a source of triadin to pull down WT or 
∆M1,2,3 RyR1. The SR was exposed to 10 mM Ca2+ to in-
hibit the interaction between CSQ and either triadin or 
junctin (Beard et al., 2005) and to minimize interactions 
between triadin and junctin (Zhang et al., 1997), before 
exposure to anti-triadin protein A/G sepharose. We found 
that exposure to 10 mM Ca2+ also dissociated triadin from 
the RyR. When the Ca2+ concentration was lowered 
appropriately, the anti-triadin/native triadin complex 
pulled down WT RyR1, but not ∆M1,2,3 RyR1, as was ob-
served using purifi  ed triadin in Fig. 1. Interestingly, in 
the light of experiments reported by Lee et al. (2006), 
we also performed experiments using anti-triadin anti-
body to pull down triadin from solubilized SR vesicles 
isolated from adult rabbit SR with either 0 or 1 mM 
Ca2+ and found that the anti-triadin antibody pulled 
down a suite of proteins that included the RyR, tria-
din, CSQ, junctin, histidine-rich protein, and several 
other unidentifi  ed proteins.
The Triadin Binding-deﬁ  cient RyR1 Mutant (∆M1,2,3) Lacks 
Electrically Evoked Ca2+ Release and Exhibits Slowed 
Kinetics of Agonist-induced Ca2+ Release
To determine the consequences of disrupting triadin 
binding to RyR1 on skeletal muscle EC coupling, we ex-
pressed either WT RyR1 or ∆M1,2,3 in myotubes derived 
from RyR1-null (dyspedic) mice. Extracellular electrical 
stimulation (Fig. 2 A, closed triangles) evoked robust 
and rapid global Ca2+ transients in intact Indo-1 AM–
loaded WT RyR1-expressing myotubes (Fig. 2 A, left), 
Figure 2.  Effects of ∆M1,2,3 on ligand-induced 
Ca2+ release. (A) Representative indo-1 ratio traces 
obtained from intact dyspedic myotubes express-
ing either WT RyR1 (left) or ∆M1,2,3 (right) fol-
lowing electrical stimulation (fi  lled triangles) and 
caffeine application (horizontal bars). (B) Average 
maximal magnitude of electrically evoked (left), 
caffeine-induced (middle), and 4-cmc–induced 
(right) Ca2+ release. (C) Average time to peak 
(TTP, left) and t1/2 of decay (middle) for caffeine-
induced Ca2+ release and time to peak 4-cmc Ca2+ 
release (TTP, right). *, P < 0.01.  Goonasekera et al. 369
but not in uninjected (naive) dyspedic myotubes (un-
published data). However, while average resting Indo-1 
ratios were not signifi  cantly different (resting F405/F485 
was 0.60 ± 0.01, n = 28, and 0.56 ± 0.01, n = 27, for WT 
RyR1- and ∆M1,2,3-expressing myotubes, respectively), 
∆M1,2,3-expressing myotubes lacked electrically evoked 
Ca2+ transients (Fig. 2 A, right, and Fig. 2 B). To confi  rm 
functional ∆M1,2,3 expression, a maximal concentration 
(30 mM) of caffeine or 4-cmc (500μM) was applied to 
both WT- and ∆M1,2,3-expressing myotubes (Fig. 2, 
A and B). Ca2+ release in response to caffeine was reduced 
in ∆M1,2,3-expressing myotubes (Fig. 2 B) and the kinetics 
of caffeine-induced and 4-cmc–induced Ca2+ release 
(time to peak and t1/2 of decay) were signifi  cantly slowed 
(Fig. 2, A and C).
The Triadin Binding-deﬁ  cient RyR1 Mutant (∆M1,2,3) 
Supports Retrograde, but not Orthograde, 
DHPR–RyR1 Coupling
Simultaneous whole-cell patch clamp measurements of 
voltage-gated L-type Ca2+ currents and intracellular 
Ca2+ transients were used to determine the ability of the 
∆M1,2,3 triadin binding-defi  cient mutant to support the 
retrograde and orthograde signals of skeletal muscle 
EC coupling (Fig. 3 A). Naive dyspedic myotubes exhib-
ited small (<1 pA/pF) L-type Ca2+ currents (Fig. 3 C, 
open squares) and lacked voltage-gated Ca2+ release 
(Fig. 3 D, open squares) (Nakai et al., 1996). Expression 
of WT RyR1 (Fig. 3 A) restored robust ( 10 pA/pF) 
voltage-gated L-type Ca2+ currents (bottom traces) and 
Ca2+ transients (top traces). Interestingly, while expres-
sion of ∆M1,2,3 (Fig. 3 B) similarly enhanced L-type Ca2+ 
current density, Ca2+ release was markedly slower and 
reduced in magnitude. Voltage-gated Ca2+ transients in 
WT RyR1-expressing myotubes exhibited the character-
istic sigmoidal voltage dependence of skeletal muscle 
EC coupling (Fig. 3 D, fi  lled circles), while Ca2+ transients 
in ∆M1,2,3-expressing myotubes exhibited a bell-shaped 
voltage dependence (Fig. 3 D, fi  lled triangles) that mir-
rored that of the L-type Ca2+ current (Fig. 3 C, fi  lled 
triangles). The bell-shaped Ca2+ transients in ∆M1,2,3-ex-
pressing myotubes largely arose from Ca2+ infl  ux–induced 
Ca2+ release through ∆M1,2,3 channels as they were 
markedly reduced by blockers of both the L-type Ca2+ 
channel (0.5 mM Cd2+ + 0.2 mM La3+, open symbols in 
Fig. 3 E) and the RyR (100μM ryanodine, open symbols 
in Fig. 3 F).
RyR1 Mutations that Disrupt Triadin Binding Do Not 
Directly Alter Release Channel Function
The observed alterations in ligand and voltage-gated Ca2+ 
release in ∆M1,2,3-expressing dyspedic myotubes docu-
mented in Figs. 2 and 3 could either be due to effects of 
the mutations on triadin regulation of RyR1 or to direct 
effects of the mutations on channel function that are 
independent of triadin binding. To test for potential 
direct effects of the mutations, we compared the sub-
cellular localization and function of WT and ∆M1,2,3 RyR1 
Figure 3.  Effects of ∆M1,2,3 on orthograde and retro-
grade DHPR-RyR1 coupling. (A) Representative L-type 
Ca2+ currents (bottom traces) and intracellular Ca2+ 
transients (top traces) resulting from 200-ms depolariza-
tions to −50, −10, +30, and +70 mV in a WT RyR1-
expressing myotube. (B) Representative L-type Ca2+ 
currents (bottom traces) and intracellular Ca2+ transients 
(top traces) resulting from 200-ms depolarizations to 
−50, −10, +30, and +70 mV in a ∆M1,2,3-expressing myo-
tube. (C and D) Average voltage dependence of peak 
L-type Ca2+ current density (C) and intracellular Ca2+ 
transients (D) in naive dyspedic myotubes (open squares), 
WT RyR1-expressing (closed circles), and ∆M1,2,3-express-
ing (closed triangles) myotubes. (E) Inhibition of L-type 
Ca2+ currents (with 0.5 mM Cd2+/0.2 mM La3+, open 
symbols) markedly reduced (86 ± 7%, n = 5 at +30 mV) 
Ca2+ transients in ∆M1,2,3-expressing myotubes (triangles) 
but only minimally reduced (16 ± 9%, n = 5 at +30 mV) 
Ca2+ transients in WT RyR1-expressing myotubes (circles). 
(F)  Blockade of Ca2+ release with 100 μM ryanodine 
(open symbols) markedly reduced depolarization-induced 
Ca2+ transients in both WT RyR1- (circles) and ∆M1,2,3-
expressing (triangles) myotubes.370 Triadin Regulation of Skeletal Muscle EC Coupling
channels following expression in HEK293 cells (Figs. 
4 and 5). WT and ∆M1,2,3 channels exhibited identical re-
ticulated ER localization (Fig. 4 A) following expression 
in HEK293 cells. Since HEK293 cells do not express tri-
adin and 4-cmc activates Ca2+ release through expressed 
RyR1 channels (Fessenden et al., 2000), we compared 
4-cmc–induced Ca2+ release responses in WT- and ∆M1,2,3-
expressing HEK293 cells. The magnitude and kinetics 
of 4-cmc–induced Ca2+ release was not signifi  cantly dif-
ferent (P > 0.05) between WT- and ∆M1,2,3-expressing 
HEK293 cells (Fig. 4, B–D).
We next compared the function of purifi  ed WT and 
∆M1,2,3 channels following expression in HEK293 cells 
(Fig. 5). WT and ∆M1,2,3 channels exhibited identical 
Ca2+ dependence of [3H]ryanodine binding, with bind-
ing (which indirectly refl  ects Po) increasing with channel 
activation between 100 nM and 10 μM cis Ca2+ (EC50 was 
4.14 ± 0.34 and 3.99 ± 0.17 μM for WT and ∆M1,2,3 chan-
nels, respectively) and then similarly declining as cis Ca2+ 
rises above 10 μM (Fig. 5 A). The data in Fig. 5 A are 
expressed relative to maximum binding in 10 μM Ca2+ 
in order to reduce variations between ER preparations. 
Maximal [3H]ryanodine binding was not signifi  cantly 
different between WT and ∆M1,2,3 channels (Bmax was 
4.8 ± 0.6 and 4.5 ± 0.1 pM/mg for WT and ∆M1,2,3 
channels, respectively). Preincubation of recombinant 
WT RyR1 channels with 5 μg/ml triadin increased 
[3H]ryanodine binding relative to binding in the absence 
of triadin. In contrast, incubation with triadin had no 
effect on maximal [3H]ryanodine binding to ∆M1,2,3 RyR1 
(Fig. 5 B). These results demonstrate a strong functional 
consequence of triadin binding to WT RyR1 and the 
lack of any functional change when triadin is added to 
triadin binding-defi  cient ∆M1,2,3 channels. Previous stud-
ies have shown an inhibitory interaction between the 
cytoplasmic domain of triadin and RyR1 (Ohkura et al., 
1998; Groh et al., 1999).
The activity of single ∆M1,2,3 channels in bilayers was 
similar to that of WT channels (Fig. 5, C–J). In six of eight 
experiments using either WT or ∆M1,2,3 channels, current 
recordings showed periods where more than one chan-
nel opened in the bilayer with similar openings in WT 
and mutant channels (Fig. 5 C). To include data from 
these recordings, open probability of 30-s recordings was 
calculated as the mean current in the recording (average 
of all data points) normalized to the maximum current 
(maximum open level), i.e., Imean/Imax (Fig. 5 D) (Beard 
et al., 2002). In each experiment, channel activity was 
initially recorded in 5 mM cis Ca2+ to aid in channel in-
corporation, cis Ca2+ concentration was then decreased 
Figure 4.  Subcellular localization and Ca2+ release 
function of WT RyR1 and ∆M1,2,3 channels expressed in 
HEK293 cells. (A) Both WT RyR1 (left) and ∆M1,2,3 
(right) channels exhibit similar reticulated ER expres-
sion. (B) Representative fura-2 ratio (F340/F380) traces 
obtained from WT RyR1- (left) and ∆M1,2,3-expressing 
(right) HEK293 cells following addition of 500 μM 
4-cmc (bar). Average peak (C) and time to peak (TTP) 
4-cmc responses (D) obtained from WT RyR1- and 
∆M1,2,3-expressing HEK293 cells.   Goonasekera et al. 371
to 10 μM and subsequently returned to 1 mM. Since 
there was no signifi  cant difference in channel activity 
between 1 or 5 mM cis Ca2+, data at these two concentra-
tions were combined and reported as ≥1 mM in Fig. 5 
(D–H). In agreement with the [3H]ryanodine binding 
data (Fig. 5 A) and previous studies (Laver et al., 1997), 
WT channel activity fell signifi  cantly when the cis Ca2+ 
concentration was increased from 10 μM to ≥1 mM Ca2+. 
However, no signifi  cant difference was observed between 
WT and ∆M1,2,3 channels (Fig. 5, D and F). All recordings 
showed periods (10–30 s) of single channel opening (Fig. 
5 C) that were also analyzed for open probability, mean 
open time, and mean closed time using a standard 20% 
threshold-crossing criterion (see Materials and methods). 
Figure 5.  Properties of puri-
fi   ed WT RyR1 and ∆M1,2,3 
channels expressed in HEK293 
cells. (A) Ca2+ dependence of 
[3H]ryanodine binding (% 
maximum binding) to WT 
(closed circles) and ∆M1,2,3 
(closed squares) channels. 
(B) Effect of preincubation 
with 5 μg/ml purifi  ed triadin 
on [3H]ryanodine binding 
in the presence of either 
100 nM or 1 mM Ca2+ (n = 
6 for each). *, P < 0.05. 
[3H]ryanodine binding to 
purifi  ed RyR1 in the presence 
of triadin (fi  lled bars) is nor-
malized to binding to purifi  ed 
RyR1 in absence of triadin 
(crosshatched bars). (C) Rep-
resentative single channel 
records from artifi  cial lipid bi-
layers incorporated with two 
purifi  ed WT (top) and two 
purifi  ed  ∆M1,2,3 (bottom) 
channels at −40 mV in the 
presence of 1 mM trans (lumi-
nal) Ca2+ and 10 μM cis (cyto-
plasmic) Ca2+. The channels 
opened from the closed level 
(c) to either single open (o1) 
and double open (o2) levels. 
(D) Average data from four 
WT RyR1 channels and four 
∆M1,2,3 channels showing 
open probability measured as 
mean current (Imean) normal-
ized to maximum current 
(Imax) during periods in which 
only one or two channels were 
open in the bilayer. Open 
probability decreased when 
the cis Ca2+ was increased 
from 10 μM to either 1 mM or 
5 mM (data for 1 and 5 mM cis 
Ca2+ at +40 and −40 mV were 
grouped in the average data). 
*, P < 0.05. (E) Periods of sin-
gle channel activity in record-
ings from bilayers containing 
purifi  ed WT (top) and ∆M1,2,3 
(bottom) channels at +40 mV 
with 1 mM trans (luminal) Ca2+ and 10 μM cis (cytoplasmic) Ca2+. (F–H) Average open probability (F), mean open time (G), and mean 
closed time (H) for 30-s recordings from four WT and four ∆M1,2,3 channels in the presence of 10 μM cis Ca2+ and combined data for 
1 and 5 mM cis Ca2+. *, P < 0.05. (I) Data from a ∆M1,2,3 channel recorded fi  rst in 100 nM cis Ca2+ (top) and then in 10 μM cis Ca2+ 
(bottom). The open probability for 30 s of channel activity at each Ca2+ concentration is given above each record. (J) Average single 
channel conductance from four WT RyR1 channels and four ∆M1,2,3 RyR1 channels.372 Triadin Regulation of Skeletal Muscle EC Coupling
Open probability values obtained with this method (Fig. 
5 F) were very similar to those estimated from Imean/Imax 
(Fig. 5 D). The decline in open probability when cis Ca2+ 
concentration was increased from 10 μM to ≥1 mM was 
due to an abbreviation of the mean open time (Fig. 5 G) 
and prolongation of the mean closed time (Fig. 5 H). 
These changes in mean open and closed times were simi-
lar in WT and ∆M1,2,3 channels.
In one experiment with a ∆M1,2,3 channel, the cis Ca2+ 
concentration was lowered to 100 nM and then increased 
to 10 μM (Fig. 5 I). As expected from the [3H]ryanodine 
binding data (Fig. 5 A), the open probability of this 
channel was greater with 10 μM cis Ca2+ than with 100 nM 
cis Ca2+, increasing from 0.15 to 0.66; the mean open time 
increased from 10.9 to 54.4 ms, and the mean closed 
time fell from 58.3 to 27.4 ms. The changes in open 
probability, mean open time, and mean closed time 
when Ca2+ concentration was increased from 100 nM to 
10 μM in this ∆M1,2,3 channel are similar to changes in 
the activity of WT channels that occur over the same 
range of Ca2+ concentrations. Finally, the ∆M1,2,3 muta-
tion did not signifi  cantly affect unitary conductance of 
RyR1 channels (Fig. 5 J) and the conductance at +40 mV 
was similar to that at −40 mV (Fig. 5, compare C with 
E or I). Average Cs+ conductance was 222 ± 19 pS for 
WT RyR1 and 207 ± 24 pS for ∆M1,2,3. Taken together, 
the data in Figs. 4 and 5 demonstrate that WT and 
∆M1,2,3 channels exhibit similar channel function in the 
absence of triadin.
Effects of Other RyR1 Luminal Loop Mutations on Ligand- 
and Voltage-gated Ca2+ Release
Indo-1 Ca2+ measurements in intact myotubes (Fig. 6) 
and whole-cell voltage clamp (Fig. 7 and Table I) exper-
iments were also conducted in myotubes expressing 
each of the single (∆M1, ∆M2, and ∆M3) and double 
(∆M1,2, ∆M2,3, and ∆M1,3) RyR1 mutations. Electrically 
evoked release (Fig. 6 A), ligand-induced release (Fig. 6, 
B–D), and both retrograde (Fig. 7 A and Table I) and 
orthograde coupling (Fig. 7 B and Table I) were not 
signifi  cantly different between WT RyR1-expressing myo-
tubes and either ∆M1-, ∆M2-, ∆M3-, or ∆M1,3-expressing 
myotubes. On the other hand, effects of the ∆M2,3 muta-
tion were similar to those of ∆M1,2,3 in that ∆M2,3-
expressing myotubes also lacked electrically evoked Ca2+ 
release (Fig. 6 A), exhibited slowed kinetics of caffeine-
induced Ca2+ release (Fig. 6, C and D), normal L-type 
Ca2+ channel activity (Fig. 7 A and Table I), and lacked 
sigmoidal voltage-gated Ca2+ release (Fig. 7 B). Interest-
ingly, reduced triadin binding to the ∆M1,2 mutant (Fig. 
1 B) was accompanied by a signifi  cant reduction in the 
magnitude of electrically evoked Ca2+ release (Fig. 6 A) 
and a slowing in ligand-induced Ca2+ release (Fig. 6, 
C and D). In patch clamp experiments, there was a ten-
dency (P = 0.05) for a reduction in voltage-gated Ca2+ 
release measured at the end of 200-ms depolarizations 
in ∆M1,2-expressing myotubes (Table I). However, for 
release assessed 30 ms after the start of the test pulse (to 
approximate release during a brief action potential), 
voltage-gated Ca2+ release (Fig. 7 C and Table I) and the 
maximum rate of Ca2+ release (Fig. 7 D), approximated 
from the peak of the fi  rst derivative of the Ca2+ transient 
elicited at +70 mV (δ(∆F/F)/δt), were signifi  cantly (P < 
0.01) reduced in ∆M1,2-expressing myotubes.
Triadin Binding-deﬁ  cient RyR1 Mutants Exhibit Normal 
Junctional Targeting
The reduction in voltage-gated Ca2+ release documented 
in ∆M1,2-, ∆M2,3-, and ∆M1,2,3- expressing myotubes (Fig. 
7, B and C) could result from a lack of proper targeting 
Figure 6.  Effects of the terminal luminal 
loop RyR1 mutants on electrically evoked 
and caffeine-induced Ca2+ release. (A–D) Bar 
graphs summarizing the effects of each of 
WT RyR1 and the different terminal RyR1 
luminal loop mutants (∆M1, ∆M2, ∆M3, 
∆M1,2, ∆M1,3, ∆M2,3, and ∆M1,2,3) on electri-
cally evoked Ca2+ release (A), peak caffeine-
induced (30 mM) Ca2+ release (B), and the 
average time to peak (C) and t1/2 of decay 
(D) of caffeine-induced Ca2+ transients.  Goonasekera et al. 373
of the mutant release channels to DHPR-containing 
SR–sarcolemmal junctions. However, our fi  nding that 
all three of these triadin binding-defi  cient mutant RyR1 
channels restored retrograde DHPR Ca2+ channel con-
ductance to a similar degree as WT RyR1 (Fig. 6 A and 
Table I) provides strong functional evidence that each 
mutant was expressed, properly targeted to SR–sarco-
lemmal junctions, and interacted with DHPRs present 
in the junction. Nevertheless, we also compared DHPR 
and RyR subcellular localization in WT-, ∆M1,2-, ∆M2,3-, 
and ∆M1,2,3-expressing myotubes in coimmunofl  uores-
cence labeling experiments (Fig. 8). Consistent with the 
observed restoration of retrograde coupling for each of 
these constructs, the RyR1 mutants that displayed de-
fects in triadin binding and electrically evoked Ca2+ re-
lease exhibited a punctate appearance (Fig. 8, left) that 
overlapped with discrete clusters of DHPR fl  uorescence 
(Fig. 8, middle). This similar punctate appearance indi-
cates correct junctional targeting of each construct and 
is particularly evident in the merged images (Fig. 8, right), 
in which green and red indicate RyR1 and DHPR, re-
spectively, and yellow represents common regions of 
punctate appearance.
DISCUSSION
Since its initial discovery in 1990 (Brandt et al., 1990), 
triadin has been shown to be enriched and embedded 
in the SR membrane of the triad (Knudson et al., 1993a), 
to interact directly with both CSQ and RyR1 (Guo and 
Campbell, 1995), to inhibit RyR channels when applied 
to the cytoplasmic side (Ohkura et al., 1998), to activate 
channels when applied to the luminal side (Gyorke et al., 
2004), and to contribute to the luminal Ca2+ transduc-
tion machinery that regulates Ca2+ release channel 
activity in skeletal muscle (Beard et al., 2004). Lee et al. 
(2004) identifi  ed three negatively charged amino acids 
(D4878, D4907, and E4908) in an RyR1 luminal loop 
that were each required for the isolated loop to bind a 
specifi  c positively charged triadin KEKE motif (residues 
Figure 7.  Effects of the terminal luminal loop 
RyR1 mutants on orthograde and retrograde cou-
pling. (A and B) Average voltage dependence of 
L-type Ca2+ current density (A) and depolariza-
tion-induced Ca2+ transients (B) in ∆M1-, ∆M2-, 
∆M3-, ∆M1,2-, ∆M1,3-, and ∆M2,3-expressing myo-
tubes. Dashed lines representing the average volt-
age dependence obtained from WT-expressing 
myotubes are shown for comparison. (C) Repre-
sentative depolarization-induced (test potential = 
+70 mV) Ca2+ transients from WT RyR1- and 
∆M1,2-expressing myotubes (top). Voltage depen-
dence of Ca2+ transients measured 30 ms after 
the start of the test pulse (bottom). (D) Differen-
tials of fl  uorescence traces (+70 mV) taken dur-
ing the initial phase of depolarization (top). Bar 
graph of average peak differential (δ(∆F/F)/δt) 
(bottom). The number of experiments is given 
within each bar. *, P < 0.01.374 Triadin Regulation of Skeletal Muscle EC Coupling
200–232) (Fig. 1 A). Our results provide the following 
important and novel contributions with regard to tria-
din binding/regulation of RyR1: (a) a single mutation to 
any of these three negatively charged residues is not suf-
fi  cient to modify RyR1–triadin association and the com-
bination of the different mutations demonstrates that 
each residue contributes unequally (D4907 > E4908 
> D4878) to triadin binding (Fig. 1 B), (b) the RyR1 
luminal loop mutations do not directly alter release chan-
nel function (Figs. 4 and 5), (c) luminal loop mutations 
that disrupt triadin binding do not alter either junctin 
binding (Fig. 1 C) or RyR1 junctional targeting (Fig. 8), 
and (d) triadin binding to RyR1 ensures rapid and robust 
Ca2+ release during both voltage- and ligand-induced 
activation (Figs. 2, 3, 6, and 7; and Table I).
Recently, Lee et al. (2006) found that triadin binding 
was reduced and the kinetics of caffeine-induced cal-
cium release slowed following infection of RyR-null 1B5 
myotubes with herpes simplex virus-1 virions packaged 
with either ∆M2 or ∆M1,2,3 compared with that observed 
for WT RyR1 (Lee et al., 2006). We found a similar slow-
ing in the kinetics of caffeine-induced calcium release 
in ∆M1,2,3-expressing primary dyspedic myotubes (Fig. 
2 C). However, unlike Lee et al. (2006), we found that 
triadin binding to RyR1 as well as the kinetics of caffeine-
induced calcium release were unaltered by the ∆M2 mu-
tation (Fig. 6, C and D). Differences between the two 
studies observed for the effects of the ∆M2 mutation are 
not entirely clear, but may involve differences between 
the cells, expression methods, and biochemical/analytical 
approaches used in the two studies.
Importantly, results presented here are the fi  rst to 
characterize the impact of triadin binding to RyR1 on 
the orthograde and retrograde signals of EC coupling. 
Specifi  cally, we found that triadin binding to RyR1 en-
hances release channel activity during both voltage and 
ligand activation and that this critical regulation of re-
lease channel activity ensures robust and rapid calcium 
release during skeletal muscle EC coupling. This idea is 
further supported by our observation that [3H]ryanodine 
binding to WT RyR1, but not ∆M1,2,3, is signifi  cantly en-
hanced by the addition of purifi  ed triadin (Fig. 5 B) and 
that triadin increases the open probability of RyR chan-
nels incorporated into planar lipid bilayers (Gyorke et al., 
2004). In addition, our study is also the fi  rst to demon-
strate that the mutations in RyR1 used to disrupt triadin 
binding do not directly affect release channel activity, 
retrograde RyR1–DHPR signaling, or the ability of junctin 
to bind to RyR1.
Defects observed for the RyR1 mutants could result 
either from effects of the mutations on triadin binding, 
direct effects on the channel, or both. We show that these 
mutations do not directly affect RyR1 channel function; 
WT and ∆M1,2,3 channels expressed in HEK293 cells 
exhibited similar Ca2+ dependence of [3H]ryanodine 
binding (Fig. 5 A), open probability (Fig. 5, D and F), 
mean open (Fig. 5 G) and closed (Fig. 5 H) times, con-
ductance (Fig. 5 J), and Ca2+ release activity (Fig. 4, B–D). 
Moreover, purifi  ed triadin increased [3H]ryanodine 
binding to WT RyR1, but not to ∆M1,2,3 (Fig. 5 B). In ad-
dition, WT RyR1 and triadin binding-defi  cient mutants 
expressed in dyspedic myotubes were activated by Ca2+ 
(Fig. 3 D), caffeine (Fig. 2 B), 4-cmc (Fig. 2 B), and fully 
restored retrograde DHPR coupling (Fig. 7 A and Table I). 
The slight reduction in maximal caffeine-induced Ca2+ 
release (Fig. 6 B) observed for the triadin binding-defi  cient 
mutants may result from a combination of slow Ca2+ re-
lease inactivating some channels and the fact that triadin 
binding to RyR1 enhances Ca2+ gating (Fig. 5 B). Finally, 
effects of the luminal loop mutants on voltage-gated 
TABLE I
Parameters of Fitted IV and FV Curves
Gmax kG VG1/2 Vrev (∆F/F)max kF VF1/2
nS/nF mV mV mV mV mV
RyR1 (n = 27)  246 ± 12 4.8 ± 0.2  9.8 ± 1.0 74.6 ± 1.5 2.5 ± 0.2 4.8 ± 0.3 −2.7 ± 0.9
RyR1 (n = 27) (30 ms)  175 ± 10 5.5 ± 0.2 12.0 ± 1.0 70.9 ± 1.3 1.4 ± 0.1 5.1 ± 0.3   2.7 ± 0.9
∆M1 (n = 17)  232 ± 9 4.7 ± 0.5  8.7 ± 1.4 74.5 ± 1.7 2.1 ± 0.2 3.6 ± 0.5 −5.1 ± 0.9
∆M2 (n = 18)  247 ± 14 5.0 ± 0.4  6.5 ± 1.5 75.7 ± 2.1 2.3 ± 0.3 4.2 ± 0.5 −2.0 ± 1.8
∆M3 (n = 12)  211 ± 17 4.6 ± 0.3 11.1 ± 0.9 68.6 ± 1.8 2.0 ± 0.2 3.6 ± 0.3 −2.4 ± 0.7
∆M1,2 (n = 12)  180 ± 11 4.5 ± 0.3  9.2 ± 1.4 76.6 ± 2.3 1.8 ± 0.3 2.9 ± 0.3   1.9 ± 1.1
∆M1,2 (n = 12) (30 ms)  132 ± 10 5.7 ± 0.2 12.3 ± 1.8 70.3 ± 2.0  0.8 ± 0.1b 4.8 ± 0.3   7.0 ± 1.1b
∆M1,3(n = 6)  259 ± 14 4.8 ± 0.3  8.9 ± 1.0 73.6 ± 2.3 2.4 ± 0.3 3.7 ± 0.6 −5.0 ± 2.5
∆M2,3 (n = 17) 187 ± 8 4.2 ± 0.4  6.9 ± 1.2 75.5 ± 2.1  0.9 ± 0.1a 3.4 ± 0.3  10.5 ± 1.3a
∆M1,2,3 (n = 18)  200 ± 11 3.6 ± 0.2 13.5 ± 1.2 75.0 ± 2.0  0.8 ± 0.1a 4.0 ± 0.3   4.3 ± 1.1a
Values represent mean ± SEM for n experiments. Parameters for the voltage dependence of Ca2+ current (I-V) and Ca2+ release (∆F/F) were obtained 
by fi  tting myotubes within each group separately to the appropriate equation (I-V, Eq. 1; ∆F/F, Eqs. 2 and 3) as described in Materials and methods. Gmax, 
maximal L-channel conductance; (∆F/F)max, maximal change in relative fl  uo-4 fl  uorescence; Vrev, L-channel reversal potential; VG1/2 and VF1/2, potential at 
which G and F are half-maximal, respectively; kG and kF, slope factors for I-V and ∆F/F, respectively.
aP < 0.01, compared to WT (200 ms).
bP < 0.01, compared to WT (30 ms).  Goonasekera et al. 375
Ca2+ release coincided perfectly with independent bio-
chemical determination of triadin binding; mutations 
that did not affect binding (∆M1, ∆M2, ∆M3, and ∆M1,3) 
did not affect orthograde coupling, mutations that 
eliminated binding abolished orthograde coupling 
(∆M1,2,3 and ∆M2,3), and mutations that partially dis-
rupted binding partially reduced orthograde coupling 
(∆M1,2). Since the binding of purifi  ed triadin to puri-
fi  ed WT or mutant RyR1 proteins in our experiments is 
likely to be thermodynamically different from in vivo 
binding that occurs in the SR, we cannot completely rule 
out the possibility that the effects of the RyR1 mutations 
on release and triadin binding are coincidentally related. 
Nevertheless, our results provide strong evidence that 
altered voltage- and ligand-induced Ca2+ release of the 
∆M1,2,3, ∆M1,2, and ∆M2,3 mutants result from defects in 
triadin binding rather than direct effects of the mutations 
on channel function.
Fig. 9 provides a simple model that ties together 
previously published results with the fi  ndings of this 
study. Under normal conditions (Fig. 9, left), triadin 
binds to both CSQ and the terminal luminal loop of 
RyR1, forming a quaternary complex along with junc-
tin that maximizes SR Ca2+ release following activation 
of RyR1 by either endogenous (e.g., DHPR) or exoge-
nous (e.g., caffeine or 4-cmc) triggers. In this model, mu-
tations in RyR1 that interfere with triadin binding are 
proposed to disrupt this critical RyR1 regulatory mecha-
nism and result in the dissociation of the triadin–CSQ 
complex from the release channel (Fig. 9, right). Since 
we found that junctin binding to RyR1 is not affected by 
any of the RyR1 luminal loop mutations, a junctin–CSQ 
Figure 8.  Triadin binding-defi  cient 
RyR1 mutants exhibit normal targeting 
to DHPR-containing junctions. (A) Dou-
ble immunofl  uorescence labeling in rep-
resentative WT- (fi  rst row), ∆M1,2- (second 
row), ∆M2,3- (third row), and ∆M1,2,3-
expressing (fourth row) myotubes with 
antibodies against RyR1 (left) and the 
DHPR (middle). The “merged images” 
(right) emphasize common regions of 
puncta (yellow foci) containing ex-
pressed RyR1 proteins and endogenous 
DHPRs in clusters that represent junc-
tions of the SR with the sarcolemma.376 Triadin Regulation of Skeletal Muscle EC Coupling
complex is shown to interact with an alternate RyR1 site 
in Fig. 9, suggesting that RyR1 activity may be differen-
tially regulated by triadin–CSQ and junctin–CSQ. Our 
results indicate that triadin binding to RyR1 primes the 
channel for ligand/voltage sensor activation in order to 
ensure rapid Ca2+ release kinetics following either volt-
age- or ligand-induced activation. In the absence of this 
critical interaction of triadin–CSQ with RyR1, the kinet-
ics of ligand- (Fig. 2 C and Fig. 6 C) and voltage-induced 
(Fig. 7, C and D) Ca2+ release is markedly slowed. In the 
case of release stimulated by a brief action potential fol-
lowing neuromuscular transmission, this reduction in 
the rate of release is suffi  cient to essentially abolish Ca2+ 
release during EC coupling (Fig. 2 B and Fig. 6 A).
Overexpression of triadin in rat skeletal myotubes 
was shown to signifi  cantly reduce KCl depolarization-
induced Ca2+ release with minimal effects on either 
caffeine-/4-cmc–induced Ca2+ release or L-type Ca2+ 
current density (Rezgui et al., 2005). Triadin overexpres-
sion could result in either increased (due to enhanced 
levels of triadin) or decreased (due to overexpression 
causing triadin aggregation, Knudson et al., 1993a) tria-
din binding to RyR1. In either case, the results of Rezgui 
et al. (2005) indicate that the EC coupling machinery is 
exquisitely sensitive to triadin– RyR1 stoichiometry. Our 
results are consistent with this notion since disruption of 
triadin binding to RyR1 also markedly reduced ortho-
grade, but not retrograde, DHPR–RyR1 coupling. The 
similar effects on voltage-gated Ca2+ release observed 
following triadin overexpression and triadin dissocia-
tion from RyR1 could be explained by effects either of 
disrupting triadin binding to RyR1 or of free triadin on 
the EC coupling machinery.
Preliminary reports have produced confl  icting results 
regarding effects of triadin defi  ciency on EC coupling. 
For example, KCl-induced Ca2+ release is similar in my-
otubes derived from WT and pan-triadin knockout mice 
(Shen, X., J.R. Lopez, P.D. Allen, and C.F. Perez. 2006. 
Biophysical Society Meeting. Abstr. 328) but signifi  -
cantly reduced and slowed following transient siRNA-
mediated knockdown of triadin and junctin in C2C12 
myotubes (Wang, Y., L. Xinghai, H. Duan, T. Fulton, 
and G. Meissner. 2007. Biophysical Society Meeting. 
Abstr. 1237). The second fi  nding is consistent with our 
results. The absence of an effect on depolarization-
induced Ca2+ release in pan-triadin knockout mice could 
result from a multitude of different compensatory mech-
anisms commandeered to correct for the loss of a critical 
RyR1 regulatory protein. In fact, skeletal muscle function 
and EC coupling is also not markedly altered following 
knockout of the skeletal muscle isoform of calsequestrin 
(CSQ1; Paolini et al., 2007). Similarly, cardiac SR Ca2+ 
storage and depolarization-induced Ca2+ release are 
essentially normal following either global knockout of 
CSQ2 (Knollmann et al., 2006) or cardiac-specifi  c knock-
out of the Na/Ca exchanger (Henderson et al., 2004), 
respectively. The surprising lack of an effect of genetic 
ablation of either CSQ1/2 or the Na/Ca exchanger 
on EC coupling certainly does not mean that these pro-
teins are not normally important for calcium storage 
and removal, respectively. Rather, remarkable compen-
satory changes in Ca2+ release unit assembly and effi  -
ciency were found to counteract CSQ and Na/Ca 
exchange defi  ciency in these animals. Conceivably, sim-
ilar compensatory changes might also account for the 
absence of a marked effect of triadin ablation of skeletal 
muscle EC coupling.
More than 15 different central core disease mutations 
in RyR1 have been identifi  ed in the terminal RyR1 luminal 
loop shown here to markedly infl  uence triadin binding 
and ligand/voltage-gated Ca2+ release. A number of these 
mutations reduce Ca2+ release without signifi  cantly affect-
ing either SR Ca2+ content or retrograde coupling to the 
DHPR (Avila et al., 2003). Thus, it will be important for fu-
ture studies to determine if any of these disease mutations 
in the RyR1 terminal luminal loop diminishes Ca2+ release 
Figure 9.  Proposed model for triadin regulation 
of DHPR and ligand activation of RyR1. The qua-
ternary CSQ–triadin–RyR1–junctin interaction 
tethers CSQ close to the release channel pore 
and promotes high probability release channel 
opening (depicted by a large arrow) following ei-
ther DHPR or ligand activation (left). Disruption 
of triadin binding to RyR1 results in a similar re-
duction in SR Ca2+ release (depicted by a small 
arrow) following either DHPR or ligand activa-
tion (right). A junctin–CSQ complex is shown to 
bind to a separate RyR1 site from that of triadin.  Goonasekera et al. 377
during EC coupling by altering the critical regulatory 
interaction of triadin with the SR Ca2+ release channel.
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